Table 1.

Demographic details of the study groups.

Study Groups	Age (Mean ± SD) [Range]	Gender Total # (M/F)
Healthy controls	38.1 ± 13.7 [19–79] years	52 (51/1)
Asymptomatic MERS-CoV patients	44.5 ± 14.8 [19–67] years	19 (3/16)
Symptomatic MERS-CoV patients	55.4 ± 18.4 [25–93] years	27 (19/8)
Symptomatic survived	50.4 ± 18 [25–93] years	19 (15/4)
Symptomatic died	67.5 ± 13.6 [50–87] years	8 (4/4)